Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)
Clinical trial NCT01697579 · COMPLETED
Trial details
- NCT number
- NCT01697579
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-13
- Primary completion
- 2016-11-21
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.